Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NJLRA
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
AbLJ-ConjE
|
|||||
| Synonyms |
AbLJ ConjE
Click to Show/Hide
|
|||||
| Organization |
ADC Therapeutics SA; MedImmune LLC
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.8
|
|||||
| Antibody Name |
Anti-CD22 mAb AbLJ
|
|||||
| Antigen Name |
B-cell receptor CD22 (CD22)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
AbLJ-ConjE linker
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||